Chronic coronary occlusion, exercise training and NO

慢性冠状动脉闭塞、运动训练与NO

基本信息

  • 批准号:
    7651232
  • 负责人:
  • 金额:
    $ 35.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-07-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Endothelial dysfunction is a major contributor to the pathogenesis of coronary artery disease and a potential therapeutic target to improve myocardial perfusion in ischemic heart disease. The role of regular exercise in the improvement of endothelial dysfunction has garnered increasing attention from both researchers and clinicians as a mechanism by which myocardial perfusion and function can be substantially improved in patients with coronary artery disease. However, the mechanisms by which exercise training reverses endothelium dysfunction are not well defined. The overall goal of the research proposed in this application is to define the specific cellular/molecular mechanisms responsible for exercise training-induced improvements in endothelium function in collateral-dependent coronary arteries and arterioles of chronically occluded hearts. Our central hypothesis is that exercise training restores endothelium-dependent vasodilatation in coronary artery disease via enhanced nitric oxide bioavailability. Specifically, Specific Aim 1 will determine the effects of exercise training on cellular and molecular mechanisms responsible for endothelium-derived nitric oxide production in collateral-dependent coronary arteries and arterioles; Specific Aim 2 will determine the effects of exercise training on the role of reactive oxygen species in agonist-mediated, nitric oxide-dependent relaxation in collateral-dependent coronary arteries and arterioles; Specific Aim 3 will determine the effects of exercise training on the interaction of nitric oxide bioavailability and Rho-kinase activity in collateral-dependent coronary arteries of occluded hearts. To address these issues, we will determine the effects of exercise training on vascular endothelial function in the well-established porcine model of chronic coronary artery occlusion. These studies will examine functional vasomotor reactivity to endotheliumdependent vasodilators, protein and mRNA expression of enzymes and factors that contribute to endothelium function, and intracellular free calcium concentration and nitric oxide production in endothelial cells. Relevance: Coronary artery disease produces more than 50% of cardiovascular disease-related deaths, the preeminant health problem of developed countries worldwide. The research proposed in this application will determine the adaptations by which exercise/physical activity improves the function of the coronary arteries and thereby increases blood flow to compromised areas of the heart in diseased patients.
描述(由申请人提供):内皮功能障碍是冠状动脉疾病发病机制的主要因素,也是缺血性心脏病改善心肌灌注的潜在治疗靶点。经常运动在改善内皮功能障碍中的作用越来越受到研究人员和临床医生的关注,因为它可以显著改善冠状动脉疾病患者的心肌灌注和功能。然而,运动训练逆转内皮功能障碍的机制尚不明确。本研究的总体目标是确定运动训练诱导慢性闭塞心脏侧支依赖性冠状动脉和小动脉内皮功能改善的特定细胞/分子机制。我们的中心假设是,运动训练通过提高一氧化氮的生物利用度来恢复冠状动脉疾病中内皮依赖性血管舒张。具体而言,Specific Aim 1将确定运动训练对侧枝依赖性冠状动脉和小动脉内皮源性一氧化氮生成的细胞和分子机制的影响;特异性目的2将确定运动训练对活性氧在激动剂介导的、一氧化氮依赖性的侧支依赖性冠状动脉和小动脉舒张中的作用的影响;特异性目的3将确定运动训练对闭塞心脏侧支依赖性冠状动脉一氧化氮生物利用度和rho激酶活性相互作用的影响。为了解决这些问题,我们将在成熟的猪慢性冠状动脉闭塞模型中确定运动训练对血管内皮功能的影响。这些研究将检查血管舒缩对内皮依赖性血管扩张剂的功能性反应性,内皮功能相关酶和因子的蛋白质和mRNA表达,内皮细胞内游离钙浓度和一氧化氮的产生。相关性:冠状动脉疾病导致50%以上的心血管疾病相关死亡,是世界发达国家的突出健康问题。本申请中提出的研究将确定运动/身体活动改善冠状动脉功能的适应性,从而增加患病患者心脏受损区域的血流量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CRISTINE L HEAPS其他文献

CRISTINE L HEAPS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CRISTINE L HEAPS', 18)}}的其他基金

Exercise training-enhanced reactive oxygen species as protective mechanisms in the coronary microcirculation
运动训练增强活性氧作为冠状动脉微循环的保护机制
  • 批准号:
    9914125
  • 财政年份:
    2018
  • 资助金额:
    $ 35.32万
  • 项目类别:
Adenosine-activation of voltage-dependent K+ currents
电压依赖性 K 电流的腺苷激活
  • 批准号:
    6584215
  • 财政年份:
    2003
  • 资助金额:
    $ 35.32万
  • 项目类别:
Adenosine-activation of voltage-dependent K+ currents
电压依赖性 K 电流的腺苷激活
  • 批准号:
    6693853
  • 财政年份:
    2002
  • 资助金额:
    $ 35.32万
  • 项目类别:
Chronic coronary occlusion, exercise training and NO
慢性冠状动脉闭塞、运动训练与NO
  • 批准号:
    7267078
  • 财政年份:
    2000
  • 资助金额:
    $ 35.32万
  • 项目类别:
Chronic coronary occlusion, exercise training and NO
慢性冠状动脉闭塞、运动训练与NO
  • 批准号:
    7880939
  • 财政年份:
    2000
  • 资助金额:
    $ 35.32万
  • 项目类别:
Chronic coronary occlusion, exercise training and NO
慢性冠状动脉闭塞、运动训练与NO
  • 批准号:
    7099840
  • 财政年份:
    2000
  • 资助金额:
    $ 35.32万
  • 项目类别:
Chronic coronary occlusion, exercise training and NO
慢性冠状动脉闭塞、运动训练与NO
  • 批准号:
    7468466
  • 财政年份:
    2000
  • 资助金额:
    $ 35.32万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 35.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了